Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
04/1997
04/08/1997US5618537 Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organ
04/08/1997US5618530 Quartenary polyallylamine
04/08/1997US5618527 Calcium polycarbophil sprinkle
04/08/1997US5618339 Substance prepared from animal bones by liming, neutralization, thermal extraction, condensation, dehydration to obtain gelatin which is deproteinized through non-heat or low temperature process
04/03/1997WO1997012055A1 Product and process to regulate actin polymerization
04/03/1997WO1997011968A2 A gene associated with liver neoplastic disease
04/03/1997WO1997011960A1 Antagonists of endothelin receptors
04/03/1997WO1997011598A1 Method for treating hepatitis virus infection
04/03/1997CA2230121A1 Product and process to regulate actin polymerization
04/02/1997EP0765871A1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors
04/02/1997EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them
04/02/1997EP0765668A1 Extract of Iridaceas and composition containing it
04/02/1997EP0765665A1 Use of dideoxy nucleoside analogues in the treatment of viral infections
04/02/1997EP0765664A1 Stable aqueous suspension of mesalazine for topical use
04/02/1997EP0765327A1 Pyrazolo and pyrrolopyridines
04/02/1997EP0765320A1 Benzimidazolone derivatives with central dopaminergic activity
04/02/1997EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
04/02/1997EP0765305A1 Anti-inflammatory compounds
04/02/1997EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same
04/02/1997EP0535048B1 Use of derivatives of human bile-salt stimulated lipase for the preparation of medicaments
04/02/1997CN1146720A New pharmaceutical formulation and preparation process
04/02/1997CN1146362A Capsule for anti hepatitis B
04/02/1997CN1146347A Kucaikaiweishu- a traditional Chinese medicine of dried herb of common saw thistle for whetting the appetite
04/01/1997US5616738 A 7-carboxybenzofuran intermediate for drugs having gastrointestinal motility stimulating properties
04/01/1997US5616592 Useful for disorders of cardiovascular, gastrointestinal and psychological disorders
04/01/1997US5616583 N- (3-hydroxy-4-piperidinyl) (benzodioxolane, benzodioxane or benzodioxepane) carboxamide derivatives
04/01/1997US5616579 Administering to mammals to prevent gastric ulcer
04/01/1997US5616556 Method of treating rheumatoid arthritis and osteoarthrosis using tetrahydro WS9326A
04/01/1997US5616346 Sodium phosphate mixtures
04/01/1997CA2042426C Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
04/01/1997CA2026030C Maltodextrin/defoaming composition combinate
03/1997
03/30/1997CA2186716A1 Hydroxypyridinones
03/29/1997CA2186717A1 Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products
03/28/1997CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them
03/27/1997WO1997011073A1 Novel substituted azacyclic or azabicyclic compounds
03/27/1997WO1997011072A1 Novel substituted azacyclic or azabicyclic compounds
03/27/1997WO1997010840A1 Anti-inflammatory antisense drug
03/27/1997WO1997010712A1 Inhibition of tumor necrosis factor alpha
03/27/1997WO1997002829A3 Use of indigestible oligosaccharides to prevent and treat diarrhea
03/27/1997WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same
03/26/1997EP0764637A2 2-Cyano-3-mercaptocrotonamides
03/26/1997EP0764208A1 Bmp-9 compositions
03/26/1997EP0764174A1 Process for removing bile salts from a patient and alkylated compositions therefor
03/26/1997EP0764166A1 Corticotropin releasing factor antagonists
03/26/1997EP0764163A1 Tachykinin (nk 1) receptor antagonists
03/26/1997EP0617624B1 Treatment of periodontal disease with alendronate
03/26/1997CN1146208A Peptides as therapeutic agents for treatment of auto-immune diseases
03/26/1997CN1146150A Low dosage ranitidine compositions
03/26/1997CN1145804A Medicine for gastropathy "kuleweikang"
03/26/1997CN1145802A Rehabilitation powder for hepatitis B
03/26/1997CN1145797A Prepn of injection with Radix Sophorae flavescentis and Radix Pulsatillae
03/26/1997CN1145786A Shanjuyangganzhiji prepn as Chinese medicine for curing hepatosis
03/26/1997CN1145781A Kappa-opiate agonists for inflammatory bowel disorders
03/26/1997CN1034333C Prepn. of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
03/25/1997US5614496 Use of fibroblast growth factors to stimulate bone growth
03/25/1997US5614209 Micro-encapsulated lactobacilli for medical applications
03/25/1997US5614198 Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
03/25/1997CA2139109C Purinone antianginal agents
03/25/1997CA2108120C Method of treating gastrointestinal ulcers with platelet derived growth factor
03/25/1997CA2067816C Muscarinic receptor antagonists
03/25/1997CA2039473C Rice dextrin oral rehydration solution
03/20/1997WO1997010254A1 Oligomers which inhibit expression of collagen genes
03/20/1997WO1997010244A1 NAPHTHAMIDE DERIVATIVES OF 3 β-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS
03/20/1997WO1997010230A1 Diarylalkenylamine derivatives
03/20/1997WO1997010207A1 Novel benzamide derivatives
03/20/1997WO1997009995A1 Method for reducing the severity of gastro-intestinal damage
03/20/1997WO1997009988A1 A biologically active preparation containing vinylene ethonium and decamethoxin
03/20/1997WO1997009980A1 Pharmaceutical formulations containing darifenacin
03/20/1997WO1997009973A2 Peripherally active anti-hyperalgesic opiates
03/20/1997CA2356097A1 Peripherally active anti-hyperalgesic opiates
03/20/1997CA2232161A1 Diarylalkenylamine derivatives
03/20/1997CA2232089A1 Oligomers which inhibit expression of collagen genes
03/20/1997CA2232082A1 Naphthamide derivatives of 3 .beta.-amino azabicyclo octane or nonane as neuroleptic agents
03/20/1997CA2205056A1 Method for reducing the severity of gastro-intestinal damage
03/20/1997CA2185850A1 2-cyano-3-mercaptocrotonamides
03/19/1997EP0763026A1 Gastrin and cck antagonists
03/19/1997EP0763012A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
03/19/1997EP0762887A1 Acylated enol derivatives as prodrugs of elastase inhibitors
03/19/1997EP0762886A1 Icam-1/lfa-1 short-chain peptides and method of using same
03/19/1997EP0667770B1 Inhibition of tnf production
03/19/1997EP0647136B1 Use of condensed bis-(3,4-dihydro-pyridinyl)methane for treating crohn's disease, colitis ulcerosa, chronic inflamatory processes and as an antiproliferative
03/19/1997EP0634998B1 Hydroxamic acid based collagenase and cytokine inhibitors
03/19/1997CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
03/19/1997CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity
03/19/1997CN1145618A New piperidine derivatives
03/19/1997CN1145364A Heterocyclic compounds and their preparation and use
03/19/1997CN1145360A Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same
03/19/1997CN1145238A Wuling C-hepatitis powder
03/18/1997US5612359 Substituted biphenyl isoxazole sulfonamides
03/18/1997US5612356 Retinoid antagonists
03/18/1997US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms
03/18/1997US5612337 Analgesic compounds for prodrugs
03/18/1997US5612334 Tricyclic benzazepine vasopressin antagonists
03/18/1997US5612314 Nitrosylated neuropeptides
03/18/1997US5612313 Controlled-pH formulation for intravesicular instillation of TGFαPE40 ab
03/18/1997US5611793 Disinfecting or sterilization tissues of mouths or wounds by applying photosensitizers
03/18/1997CA2037101C Omeprazole compositions designed for administration in rectum
03/13/1997WO1997009349A1 Binding protein
03/13/1997WO1997009329A1 Azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel disease
03/13/1997WO1997009056A1 Extract of iridaceae and compositions containing such extract